French pharmaceutical glass manufacturer SGD Pharma is be sold to a European private equity organization.
SGD Pharma’s owners China Jianyin Investment (JIC) are in final negotiations with PAI Partners over the deal.
Christophe Nicoli, Chief Executive Officer of SGD Pharma, says: “By investing in cutting-edge manufacturing technologies, in taking the lead on sustainability and through constantly improving the service level it offers to its clients, the SGD Pharma teams have built a solid platform for performance and growth under JIC’s ownership.
Laurent Rivoire, a Managing Partner at PAI Partners, said: “We look forward to finalizing the acquisition of SGD Pharma from JIC.
“We have closely followed the development of SGD Pharma over the years and have been impressed by the progress made under the leadership of a talented management team.
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.